4th Quarter - Report

THE UNITED STATES PHARMACOPEIAL CONVENTION for THE UNITED STATES PHARMACOPEIAL CONVENTION

Firm
Client
Income
—
Expenses
$100,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017 USP initiative on opioids. Role of standards in facilitating competition. S. 2042, Reducing Drug Waste Act of 2017; all provisions S. 1003, A bill to amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes; all provisions

LobbyistCovered position, as disclosed
CARRIE HARNEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2871 (115th), S. 2042 (115th), S. 1003 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.